NCT02746380View on ClinicalTrials.gov

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

April 13, 2016

Primary Completion Date

July 14, 2017

Study Completion Date

February 23, 2018

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

LBAL

Adalimumab

DRUG

Humira®

Adalimumab

Trial Locations (2)

Unknown

Mochida Investigational site, Tokyo

LGLS Investigational site, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
collaborator

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

lead

LG Life Sciences

INDUSTRY